Target Gene/Pathway Pathway / Gene


Search results


No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related
KEGG GENES KEGG DRUG DrugBank 指定難病告示番号
1 Acute myeloid leukemia 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
2 Acute myeloid leukemia 💬
2件: PML, RARA 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
3 Adipocytokine signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
4 Alcoholism 💬
1件: ADORA2B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
5 Alcoholism 💬
1件: ADORA2B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
6 Aldosterone synthesis and secretion 💬
1件: PDE2A 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
7 Aldosterone synthesis and secretion 💬
1件: PDE2A 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
8 Allograft rejection 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
9 Alzheimer disease 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
10 Alzheimer disease 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
11 Alzheimer disease 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 18件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 228, 256, 283, 288, 331 💬
12 Alzheimer disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
13 Alzheimer disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
14 Amphetamine addiction 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
15 AMPK signaling pathway 💬
1件: HMGCR 💬 Atorvastatin calcium 💬 Atorvastatin 20件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬
16 AMPK signaling pathway 💬
1件: HMGCR 💬 Atorvastatin 💬 Atorvastatin 20件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬
17 AMPK signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
18 Amyotrophic lateral sclerosis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
19 Amyotrophic lateral sclerosis 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
20 Amyotrophic lateral sclerosis 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 18件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 228, 256, 283, 288, 331 💬
21 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
22 Amyotrophic lateral sclerosis 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
23 Apelin signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
24 Apelin signaling pathway 💬
1件: PDE3B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
25 Apelin signaling pathway 💬
1件: PDE3B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
26 Asthma 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
27 Autoimmune thyroid disease 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
28 Autophagy - animal 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
29 Autophagy - other 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
30 Axon guidance 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
31 B cell receptor signaling pathway 💬
1件: BTK 💬 Orelabrutinib 💬 Orelabrutinib 4件: 13, 49, 61, 63 💬
32 B cell receptor signaling pathway 💬
1件: BTK 💬 Rilzabrutinib 💬 Rilzabrutinib 5件: 35, 61, 63, 222, 300 💬
33 B cell receptor signaling pathway 💬
1件: BTK 💬 Zanubrutinib 💬 Zanubrutinib 6件: 13, 61, 63, 222, 300, 331 💬
34 B cell receptor signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
35 B cell receptor signaling pathway 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
36 B cell receptor signaling pathway 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
37 Bile secretion 💬
1件: HMGCR 💬 Atorvastatin calcium 💬 Atorvastatin 20件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬
38 Bile secretion 💬
1件: HMGCR 💬 Atorvastatin 💬 Atorvastatin 20件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬
39 Breast cancer 💬
2件: ESR1, PGR 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
40 Breast cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
41 C-type lectin receptor signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
42 C-type lectin receptor signaling pathway 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
43 C-type lectin receptor signaling pathway 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
44 Calcium signaling pathway 💬
4件: ADORA2B, PDE1, PDE1, PDE1 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
45 Calcium signaling pathway 💬
4件: ADORA2B, PDE1, PDE1, PDE1 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
46 Calcium signaling pathway 💬
1件: CD38 💬 Daratumumab 💬 Daratumumab 10件: 13, 16, 28, 46, 48, 49, 60, 63, 288, 331 💬
47 Calcium signaling pathway 💬
1件: CD38 💬 Mezagitamab 💬 Mezagitamab 2件: 63, 66 💬
48 Calcium signaling pathway 💬
1件: CYSLTR1 💬 Montelukast sodium 💬 Montelukast 9件:  6 , 13, 19, 46, 61, 63, 85, 98, 228 💬
49 Calcium signaling pathway 💬
1件: CYSLTR1 💬 Montelukast 💬 Montelukast 9件:  6 , 13, 19, 46, 61, 63, 85, 98, 228 💬
50 Calcium signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
51 cAMP signaling pathway 💬
8件: ADORA1, PDE10, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
52 cAMP signaling pathway 💬
8件: ADORA1, PDE10, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
53 Cell adhesion molecules 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
54 Cellular senescence 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
55 Cellular senescence 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
56 Central carbon metabolism in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
57 cGMP-PKG signaling pathway 💬
4件: ADORA1, PDE2A, PDE3A, PDE3B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
58 cGMP-PKG signaling pathway 💬
4件: ADORA1, PDE2A, PDE3A, PDE3B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
59 cGMP-PKG signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
60 Chemical carcinogenesis - receptor activation 💬
3件: AR, ESR1, PGR 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
61 Chemical carcinogenesis - receptor activation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
62 Choline metabolism in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
63 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Lansoprazole 💬 Lansoprazole 6件: 63, 71, 85, 166, 222, 299 💬
64 Collecting duct acid secretion 💬
2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
65 Colorectal cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
66 Complement and coagulation cascades 💬
1件: VWF 💬 Caplacizumab 💬 Caplacizumab 2件: 63, 64 💬
67 Coronavirus disease - COVID-19 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
68 Coronavirus disease - COVID-19 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
69 Coronavirus disease - COVID-19 💬
1件: VWF 💬 Caplacizumab 💬 Caplacizumab 2件: 63, 64 💬
70 Cortisol synthesis and secretion 💬
2件: PDE8, PDE8 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
71 Cortisol synthesis and secretion 💬
2件: PDE8, PDE8 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
72 Cushing syndrome 💬
3件: PDE11, PDE8, PDE8 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
73 Cushing syndrome 💬
3件: PDE11, PDE8, PDE8 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
74 Cysteine and methionine metabolism 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 Decitabine 💬 Decitabine 3件: 13, 60, 63 💬
75 Cytokine-cytokine receptor interaction 💬
1件: TNFRSF13B 💬 Povetacicept 💬 Povetacicept 3件: 61, 63, 222 💬
76 Cytokine-cytokine receptor interaction 💬
1件: TNFRSF13C 💬 Ianalumab 💬 Ianalumab 8件: 35, 46, 49, 51, 53, 61, 63, 95 💬
77 Cytokine-cytokine receptor interaction 💬
1件: TNFSF13B 💬 Belimumab 💬 Belimumab 14件: 11, 13, 43, 44, 46, 48, 49, 51, 53, 63, 66, 95, 222, 296 💬
78 Cytokine-cytokine receptor interaction 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
79 Cytokine-cytokine receptor interaction 💬
1件: TPOR 💬 Avatrombopag 💬 Avatrombopag 2件: 60, 63 💬
80 Cytokine-cytokine receptor interaction 💬
1件: TPOR 💬 Avatrombopag maleate 💬 Avatrombopag 2件: 60, 63 💬
81 Cytokine-cytokine receptor interaction 💬
1件: TPOR 💬 Eltrombopag olamine 💬 Eltrombopag 5件: 60, 63, 65, 284, 285 💬
82 Cytokine-cytokine receptor interaction 💬
1件: TPOR 💬 Eltrombopag choline 💬 Eltrombopag 5件: 60, 63, 65, 284, 285 💬
83 Cytokine-cytokine receptor interaction 💬
1件: TPOR 💬 Lusutrombopag 💬 Lusutrombopag 2件: 60, 63 💬
84 Cytokine-cytokine receptor interaction 💬
1件: TPOR 💬 Romiplostim 💬 Romiplostim 4件: 60, 63, 64, 65 💬
85 Diabetic cardiomyopathy 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
86 Dopaminergic synapse 💬
3件: PPP3C, PPP3C, PPP3C 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
87 Drug metabolism - other enzymes 💬
2件: IMPDH, IMPDH 💬 Mycophenolate mofetil hydrochloride 💬 Mycophenolate mofetil 34件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
88 Drug metabolism - other enzymes 💬
2件: IMPDH, IMPDH 💬 Mycophenolate sodium 💬 Mycophenolic acid 37件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
89 Drug metabolism - other enzymes 💬
2件: IMPDH, IMPDH 💬 Mycophenolic acid 💬 Mycophenolic acid 37件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
90 Drug metabolism - other enzymes 💬
2件: IMPDH, IMPDH 💬 Mycophenolate mofetil 💬 Mycophenolate mofetil 34件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
91 ECM-receptor interaction 💬
1件: VWF 💬 Caplacizumab 💬 Caplacizumab 2件: 63, 64 💬
92 Efferocytosis 💬
1件: DNMT3A 💬 Decitabine 💬 Decitabine 3件: 13, 60, 63 💬
93 Endocrine and other factor-regulated calcium reabsorption 💬
1件: ESR1 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
94 Endocytosis 💬
1件: PML 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
95 Epstein-Barr virus infection 💬
1件: BTK 💬 Orelabrutinib 💬 Orelabrutinib 4件: 13, 49, 61, 63 💬
96 Epstein-Barr virus infection 💬
1件: BTK 💬 Rilzabrutinib 💬 Rilzabrutinib 5件: 35, 61, 63, 222, 300 💬
97 Epstein-Barr virus infection 💬
1件: BTK 💬 Zanubrutinib 💬 Zanubrutinib 6件: 13, 61, 63, 222, 300, 331 💬
98 Epstein-Barr virus infection 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
99 Epstein-Barr virus infection 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
100 ErbB signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
101 Estrogen signaling pathway 💬
2件: ESR1, PGR 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
102 Estrogen signaling pathway 💬
1件: RARA 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
103 Fc epsilon RI signaling pathway 💬
1件: BTK 💬 Orelabrutinib 💬 Orelabrutinib 4件: 13, 49, 61, 63 💬
104 Fc epsilon RI signaling pathway 💬
1件: BTK 💬 Rilzabrutinib 💬 Rilzabrutinib 5件: 35, 61, 63, 222, 300 💬
105 Fc epsilon RI signaling pathway 💬
1件: BTK 💬 Zanubrutinib 💬 Zanubrutinib 6件: 13, 61, 63, 222, 300, 331 💬
106 Fc epsilon RI signaling pathway 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
107 Fc epsilon RI signaling pathway 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
108 Fc gamma R-mediated phagocytosis 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
109 Fc gamma R-mediated phagocytosis 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
110 Focal adhesion 💬
1件: VWF 💬 Caplacizumab 💬 Caplacizumab 2件: 63, 64 💬
111 Gap junction 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
112 Gap junction 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
113 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Lansoprazole 💬 Lansoprazole 6件: 63, 71, 85, 166, 222, 299 💬
114 Gastric acid secretion 💬
2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
115 Gastric cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
116 Gastric cancer 💬
1件: RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
117 Glioma 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
118 Glucagon signaling pathway 💬
1件: PDE3B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
119 Glucagon signaling pathway 💬
1件: PDE3B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
120 Glucagon signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
121 Glutamatergic synapse 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
122 Growth hormone synthesis, secretion and action 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
123 Hematopoietic cell lineage 💬
1件: CD38 💬 Daratumumab 💬 Daratumumab 10件: 13, 16, 28, 46, 48, 49, 60, 63, 288, 331 💬
124 Hematopoietic cell lineage 💬
1件: CD38 💬 Mezagitamab 💬 Mezagitamab 2件: 63, 66 💬
125 Hematopoietic cell lineage 💬
1件: MS4A1 💬 Obinutuzumab 💬 Obinutuzumab 5件: 43, 44, 49, 63, 222 💬
126 Hematopoietic cell lineage 💬
1件: MS4A1 💬 Rituximab 💬 Rituximab 52件: 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
127 Hematopoietic cell lineage 💬
1件: MS4A1 💬 Veltuzumab 💬 Veltuzumab 2件: 46, 63 💬
128 Hepatocellular carcinoma 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
129 Herpes simplex virus 1 infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
130 Herpes simplex virus 1 infection 💬
1件: PML 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
131 Herpes simplex virus 1 infection 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
132 Herpes simplex virus 1 infection 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
133 HIF-1 signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
134 Hormone signaling 💬
1件: ESR1 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
135 Hormone signaling 💬
1件: TPOR 💬 Avatrombopag 💬 Avatrombopag 2件: 60, 63 💬
136 Hormone signaling 💬
1件: TPOR 💬 Avatrombopag maleate 💬 Avatrombopag 2件: 60, 63 💬
137 Hormone signaling 💬
1件: TPOR 💬 Eltrombopag olamine 💬 Eltrombopag 5件: 60, 63, 65, 284, 285 💬
138 Hormone signaling 💬
1件: TPOR 💬 Eltrombopag choline 💬 Eltrombopag 5件: 60, 63, 65, 284, 285 💬
139 Hormone signaling 💬
1件: TPOR 💬 Lusutrombopag 💬 Lusutrombopag 2件: 60, 63 💬
140 Hormone signaling 💬
1件: TPOR 💬 Romiplostim 💬 Romiplostim 4件: 60, 63, 64, 65 💬
141 Human cytomegalovirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
142 Human cytomegalovirus infection 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
143 Human immunodeficiency virus 1 infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
144 Human immunodeficiency virus 1 infection 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
145 Human papillomavirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
146 Human papillomavirus infection 💬
1件: VWF 💬 Caplacizumab 💬 Caplacizumab 2件: 63, 64 💬
147 Human T-cell leukemia virus 1 infection 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
148 Human T-cell leukemia virus 1 infection 💬
1件: TNFRSF13C 💬 Ianalumab 💬 Ianalumab 8件: 35, 46, 49, 51, 53, 61, 63, 95 💬
149 Huntington disease 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
150 Huntington disease 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 18件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 228, 256, 283, 288, 331 💬
151 Huntington disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
152 Huntington disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
153 Influenza A 💬
1件: PML 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
154 Insulin resistance 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
155 Insulin signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
156 Insulin signaling pathway 💬
1件: PDE3B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
157 Insulin signaling pathway 💬
1件: PDE3B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
158 Intestinal immune network for IgA production 💬
1件: TNFRSF13B 💬 Povetacicept 💬 Povetacicept 3件: 61, 63, 222 💬
159 Intestinal immune network for IgA production 💬
1件: TNFRSF13C 💬 Ianalumab 💬 Ianalumab 8件: 35, 46, 49, 51, 53, 61, 63, 95 💬
160 Intestinal immune network for IgA production 💬
1件: TNFSF13B 💬 Belimumab 💬 Belimumab 14件: 11, 13, 43, 44, 46, 48, 49, 51, 53, 63, 66, 95, 222, 296 💬
161 Intestinal immune network for IgA production 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
162 JAK-STAT signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
163 JAK-STAT signaling pathway 💬
1件: TPOR 💬 Avatrombopag 💬 Avatrombopag 2件: 60, 63 💬
164 JAK-STAT signaling pathway 💬
1件: TPOR 💬 Avatrombopag maleate 💬 Avatrombopag 2件: 60, 63 💬
165 JAK-STAT signaling pathway 💬
1件: TPOR 💬 Eltrombopag olamine 💬 Eltrombopag 5件: 60, 63, 65, 284, 285 💬
166 JAK-STAT signaling pathway 💬
1件: TPOR 💬 Eltrombopag choline 💬 Eltrombopag 5件: 60, 63, 65, 284, 285 💬
167 JAK-STAT signaling pathway 💬
1件: TPOR 💬 Lusutrombopag 💬 Lusutrombopag 2件: 60, 63 💬
168 JAK-STAT signaling pathway 💬
1件: TPOR 💬 Romiplostim 💬 Romiplostim 4件: 60, 63, 64, 65 💬
169 Kaposi sarcoma-associated herpesvirus infection 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
170 Kaposi sarcoma-associated herpesvirus infection 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
171 Kaposi sarcoma-associated herpesvirus infection 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
172 Kaposi sarcoma-associated herpesvirus infection 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
173 Lipid and atherosclerosis 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
174 Lipid and atherosclerosis 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
175 Long-term potentiation 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
176 Longevity regulating pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
177 Longevity regulating pathway - multiple species 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
178 Malaria 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
179 MAPK signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
180 MicroRNAs in cancer 💬
3件: DNMT1, DNMT3A, DNMT3B 💬 Decitabine 💬 Decitabine 3件: 13, 60, 63 💬
181 MicroRNAs in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
182 Morphine addiction 💬
17件: ADORA1, PDE1, PDE1, PDE1, PDE10, PDE11, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE7, PDE7, PDE8, PDE8 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
183 Morphine addiction 💬
17件: ADORA1, PDE1, PDE1, PDE1, PDE10, PDE11, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE7, PDE7, PDE8, PDE8 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
184 Motor proteins 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
185 Motor proteins 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
186 mTOR signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
187 Natural killer cell mediated cytotoxicity 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
188 Natural killer cell mediated cytotoxicity 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
189 Natural killer cell mediated cytotoxicity 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
190 Neuroactive ligand signaling 💬
2件: ADORA1, ADORA2B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
191 Neuroactive ligand signaling 💬
2件: ADORA1, ADORA2B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
192 Neuroactive ligand-receptor interaction 💬
2件: ADORA1, ADORA2B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
193 Neuroactive ligand-receptor interaction 💬
2件: ADORA1, ADORA2B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
194 Neuroactive ligand-receptor interaction 💬
1件: CYSLTR1 💬 Montelukast sodium 💬 Montelukast 9件:  6 , 13, 19, 46, 61, 63, 85, 98, 228 💬
195 Neuroactive ligand-receptor interaction 💬
1件: CYSLTR1 💬 Montelukast 💬 Montelukast 9件:  6 , 13, 19, 46, 61, 63, 85, 98, 228 💬
196 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone 💬 Dexamethasone 25件: 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
197 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone sodium phosphate 💬 Dexamethasone 25件: 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
198 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone phosphate 💬 Dexamethasone 25件: 13, 14, 16, 19, 28, 35, 53, 63, 64, 65, 70, 74, 75, 81, 84, 90, 96, 97, 162, 222, 235, 257, 296, 299, 331 💬
199 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Dexamethasone palmitate 💬 Dexamethasone palmitate 1件: 63 💬
200 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Methylprednisolone 💬 Methylprednisolone 48件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
201 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Methylprednisolone acetate 💬 Methylprednisolone 48件:  2 ,  6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 127, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 💬
202 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Prednisolone 💬 Prednisolone 41件:  3 , 11, 13, 14, 18, 25, 26, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 54, 56, 60, 61, 63, 64, 66, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 251, 269, 271, 296, 299, 300 💬
203 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Prednisone 💬 Prednisone 54件:  2 , 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
204 Neuroactive ligand-receptor interaction 💬
1件: NR3C1 💬 Prednisone acetate 💬 Prednisone acetate 9件: 35, 40, 41, 46, 49, 63, 162, 222, 224 💬
205 Neutrophil extracellular trap formation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
206 Neutrophil extracellular trap formation 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
207 Neutrophil extracellular trap formation 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
208 Neutrophil extracellular trap formation 💬
1件: VWF 💬 Caplacizumab 💬 Caplacizumab 2件: 63, 64 💬
209 NF-kappa B signaling pathway 💬
1件: BTK 💬 Orelabrutinib 💬 Orelabrutinib 4件: 13, 49, 61, 63 💬
210 NF-kappa B signaling pathway 💬
1件: BTK 💬 Rilzabrutinib 💬 Rilzabrutinib 5件: 35, 61, 63, 222, 300 💬
211 NF-kappa B signaling pathway 💬
1件: BTK 💬 Zanubrutinib 💬 Zanubrutinib 6件: 13, 61, 63, 222, 300, 331 💬
212 NF-kappa B signaling pathway 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
213 NF-kappa B signaling pathway 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
214 NF-kappa B signaling pathway 💬
1件: TNFRSF13C 💬 Ianalumab 💬 Ianalumab 8件: 35, 46, 49, 51, 53, 61, 63, 95 💬
215 NF-kappa B signaling pathway 💬
1件: TNFSF13B 💬 Belimumab 💬 Belimumab 14件: 11, 13, 43, 44, 46, 48, 49, 51, 53, 63, 66, 95, 222, 296 💬
216 NF-kappa B signaling pathway 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
217 Nicotinate and nicotinamide metabolism 💬
1件: CD38 💬 Daratumumab 💬 Daratumumab 10件: 13, 16, 28, 46, 48, 49, 60, 63, 288, 331 💬
218 Nicotinate and nicotinamide metabolism 💬
1件: CD38 💬 Mezagitamab 💬 Mezagitamab 2件: 63, 66 💬
219 Non-small cell lung cancer 💬
1件: RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
220 Olfactory transduction 💬
4件: PDE1, PDE1, PDE1, PDE2A 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
221 Olfactory transduction 💬
4件: PDE1, PDE1, PDE1, PDE2A 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
222 Oocyte meiosis 💬
2件: AR, PGR 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
223 Oocyte meiosis 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
224 Osteoclast differentiation 💬
1件: BTK 💬 Orelabrutinib 💬 Orelabrutinib 4件: 13, 49, 61, 63 💬
225 Osteoclast differentiation 💬
1件: BTK 💬 Rilzabrutinib 💬 Rilzabrutinib 5件: 35, 61, 63, 222, 300 💬
226 Osteoclast differentiation 💬
1件: BTK 💬 Zanubrutinib 💬 Zanubrutinib 6件: 13, 61, 63, 222, 300, 331 💬
227 Osteoclast differentiation 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
228 Osteoclast differentiation 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
229 Osteoclast differentiation 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
230 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Lansoprazole 💬 Lansoprazole 6件: 63, 71, 85, 166, 222, 299 💬
231 Oxidative phosphorylation 💬
2件: ATP4A, ATP4B 💬 Vonoprazan 💬 Vonoprazan 3件: 63, 97, 98 💬
232 Oxytocin signaling pathway 💬
1件: CD38 💬 Daratumumab 💬 Daratumumab 10件: 13, 16, 28, 46, 48, 49, 60, 63, 288, 331 💬
233 Oxytocin signaling pathway 💬
1件: CD38 💬 Mezagitamab 💬 Mezagitamab 2件: 63, 66 💬
234 Oxytocin signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
235 Pancreatic cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
236 Pancreatic secretion 💬
1件: CD38 💬 Daratumumab 💬 Daratumumab 10件: 13, 16, 28, 46, 48, 49, 60, 63, 288, 331 💬
237 Pancreatic secretion 💬
1件: CD38 💬 Mezagitamab 💬 Mezagitamab 2件: 63, 66 💬
238 Parathyroid hormone synthesis, secretion and action 💬
4件: PDE4, PDE4, PDE4, PDE4 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
239 Parathyroid hormone synthesis, secretion and action 💬
4件: PDE4, PDE4, PDE4, PDE4 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
240 Parkinson disease 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 18件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 228, 256, 283, 288, 331 💬
241 Parkinson disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
242 Parkinson disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
243 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
244 Pathogenic Escherichia coli infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
245 Pathways in cancer 💬
2件: AR, ESR1 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
246 Pathways in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
247 Pathways in cancer 💬
3件: PML, RARA, RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
248 Pathways of neurodegeneration - multiple diseases 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
249 Pathways of neurodegeneration - multiple diseases 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
250 Pathways of neurodegeneration - multiple diseases 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 18件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 228, 256, 283, 288, 331 💬
251 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
252 Pathways of neurodegeneration - multiple diseases 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
253 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
254 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
255 Phagosome 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
256 Phagosome 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
257 Phospholipase D signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
258 Phospholipase D signaling pathway 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
259 Phospholipase D signaling pathway 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
260 PI3K-Akt signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
261 PI3K-Akt signaling pathway 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
262 PI3K-Akt signaling pathway 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
263 PI3K-Akt signaling pathway 💬
1件: VWF 💬 Caplacizumab 💬 Caplacizumab 2件: 63, 64 💬
264 Platelet activation 💬
1件: BTK 💬 Orelabrutinib 💬 Orelabrutinib 4件: 13, 49, 61, 63 💬
265 Platelet activation 💬
1件: BTK 💬 Rilzabrutinib 💬 Rilzabrutinib 5件: 35, 61, 63, 222, 300 💬
266 Platelet activation 💬
1件: BTK 💬 Zanubrutinib 💬 Zanubrutinib 6件: 13, 61, 63, 222, 300, 331 💬
267 Platelet activation 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
268 Platelet activation 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
269 Platelet activation 💬
1件: VWF 💬 Caplacizumab 💬 Caplacizumab 2件: 63, 64 💬
270 Primary immunodeficiency 💬
1件: BTK 💬 Orelabrutinib 💬 Orelabrutinib 4件: 13, 49, 61, 63 💬
271 Primary immunodeficiency 💬
1件: BTK 💬 Rilzabrutinib 💬 Rilzabrutinib 5件: 35, 61, 63, 222, 300 💬
272 Primary immunodeficiency 💬
1件: BTK 💬 Zanubrutinib 💬 Zanubrutinib 6件: 13, 61, 63, 222, 300, 331 💬
273 Primary immunodeficiency 💬
1件: TNFRSF13B 💬 Povetacicept 💬 Povetacicept 3件: 61, 63, 222 💬
274 Primary immunodeficiency 💬
1件: TNFRSF13C 💬 Ianalumab 💬 Ianalumab 8件: 35, 46, 49, 51, 53, 61, 63, 95 💬
275 Primary immunodeficiency 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
276 Prion disease 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
277 Prion disease 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 18件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 228, 256, 283, 288, 331 💬
278 Prion disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
279 Prion disease 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
280 Progesterone-mediated oocyte maturation 💬
1件: PDE3B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
281 Progesterone-mediated oocyte maturation 💬
1件: PDE3B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
282 Progesterone-mediated oocyte maturation 💬
1件: PGR 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
283 Prolactin signaling pathway 💬
1件: ESR1 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
284 Prostate cancer 💬
1件: AR 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
285 Prostate cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
286 Proteasome 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 18件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 228, 256, 283, 288, 331 💬
287 Proteoglycans in cancer 💬
1件: ESR1 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
288 Proteoglycans in cancer 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
289 Purine metabolism 💬
2件: IMPDH, IMPDH 💬 Mycophenolate mofetil 💬 Mycophenolate mofetil 34件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
290 Purine metabolism 💬
2件: IMPDH, IMPDH 💬 Mycophenolate mofetil hydrochloride 💬 Mycophenolate mofetil 34件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
291 Purine metabolism 💬
2件: IMPDH, IMPDH 💬 Mycophenolic acid 💬 Mycophenolic acid 37件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
292 Purine metabolism 💬
2件: IMPDH, IMPDH 💬 Mycophenolate sodium 💬 Mycophenolic acid 37件:  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 45, 46, 49, 51, 53, 60, 61, 62, 63, 65, 66, 84, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
293 Purine metabolism 💬
16件: PDE1, PDE1, PDE1, PDE10, PDE11, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE7, PDE7, PDE8, PDE8 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
294 Purine metabolism 💬
16件: PDE1, PDE1, PDE1, PDE10, PDE11, PDE2A, PDE3A, PDE3B, PDE4, PDE4, PDE4, PDE4, PDE7, PDE7, PDE8, PDE8 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
295 Pyrimidine metabolism 💬
1件: DHODH 💬 Teriflunomide 💬 Teriflunomide 4件: 13, 25, 26, 63 💬
296 Rap1 signaling pathway 💬
1件: ADORA2B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
297 Rap1 signaling pathway 💬
1件: ADORA2B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
298 Regulation of lipolysis in adipocytes 💬
2件: ADORA1, PDE3B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
299 Regulation of lipolysis in adipocytes 💬
2件: ADORA1, PDE3B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
300 Renin secretion 💬
6件: ADORA1, PDE1, PDE1, PDE1, PDE3A, PDE3B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
301 Renin secretion 💬
6件: ADORA1, PDE1, PDE1, PDE1, PDE3A, PDE3B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
302 Renin secretion 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
303 Rheumatoid arthritis 💬
1件: TNFSF13B 💬 Belimumab 💬 Belimumab 14件: 11, 13, 43, 44, 46, 48, 49, 51, 53, 63, 66, 95, 222, 296 💬
304 Salivary secretion 💬
1件: CD38 💬 Daratumumab 💬 Daratumumab 10件: 13, 16, 28, 46, 48, 49, 60, 63, 288, 331 💬
305 Salivary secretion 💬
1件: CD38 💬 Mezagitamab 💬 Mezagitamab 2件: 63, 66 💬
306 Salmonella infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine sulfate 💬 Vinblastine 3件: 34, 63, 65 💬
307 Salmonella infection 💬
9件: TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬 Vinblastine 💬 Vinblastine 3件: 34, 63, 65 💬
308 Shigellosis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
309 Small cell lung cancer 💬
1件: RARB 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
310 Sphingolipid signaling pathway 💬
1件: ADORA1 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
311 Sphingolipid signaling pathway 💬
1件: ADORA1 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
312 Spinocerebellar ataxia 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
313 Spinocerebellar ataxia 💬
1件: PSMB5 💬 Bortezomib 💬 Bortezomib 18件: 11, 13, 26, 28, 46, 49, 51, 61, 63, 64, 66, 172, 222, 228, 256, 283, 288, 331 💬
314 Systemic lupus erythematosus 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
315 T cell receptor signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
316 T cell receptor signaling pathway 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
317 Taste transduction 💬
3件: PDE1, PDE1, PDE1 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
318 Taste transduction 💬
3件: PDE1, PDE1, PDE1 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
319 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Atorvastatin calcium 💬 Atorvastatin 20件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬
320 Terpenoid backbone biosynthesis 💬
1件: HMGCR 💬 Atorvastatin 💬 Atorvastatin 20件: 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬
321 Th1 and Th2 cell differentiation 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
322 Th17 cell differentiation 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
323 Th17 cell differentiation 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
324 Th17 cell differentiation 💬
1件: RARA 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
325 Thermogenesis 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
326 Thyroid hormone signaling pathway 💬
1件: ESR1 💬 Danazol 💬 Danazol 5件: 60, 63, 64, 65, 285 💬
327 Thyroid hormone signaling pathway 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
328 Toxoplasmosis 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
329 Transcriptional misregulation in cancer 💬
2件: PML, RARA 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
330 Tuberculosis 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
331 Tuberculosis 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
332 Tuberculosis 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
333 Type II diabetes mellitus 💬
1件: MTOR 💬 Sirolimus 💬 Sirolimus 46件:  2 ,  6 , 13, 15, 17, 19, 21, 34, 35, 36, 46, 48, 49, 51, 53, 60, 61, 62, 63, 65, 66, 67, 84, 85, 86, 89, 96, 97, 98, 137, 157, 158, 192, 193, 222, 227, 256, 277, 278, 279, 280, 281, 283, 285, 300, 331 💬
334 Ubiquitin mediated proteolysis 💬
1件: PML 💬 Tretinoin 💬 Tretinoin 6件:  2 , 62, 63, 75, 94, 231 💬
335 Vascular smooth muscle contraction 💬
1件: ADORA2B 💬 Aminophylline 💬 Aminophylline 1件: 63 💬
336 Vascular smooth muscle contraction 💬
1件: ADORA2B 💬 Aminophylline dihydrate 💬 Aminophylline 1件: 63 💬
337 VEGF signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
338 Viral carcinogenesis 💬
1件: SYK 💬 Fostamatinib 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
339 Viral carcinogenesis 💬
1件: SYK 💬 Fostamatinib disodium 💬 Fostamatinib 5件: 46, 49, 61, 63, 66 💬
340 Viral myocarditis 💬
1件: TNFSF5 💬 Toralizumab 💬 Toralizumab 1件: 63 💬
341 Wnt signaling pathway 💬
5件: PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬 Cyclosporine 💬 Cyclosporine 42件: 11, 19, 20, 26, 28, 36, 40, 41, 42, 45, 46, 49, 50, 53, 54, 55, 56, 58, 60, 61, 62, 63, 64, 65, 93, 95, 97, 107, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬